194 related articles for article (PubMed ID: 10683542)
21. Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers.
Zhou S; Li T; Allain JP; Zhou B; Zhang Y; Zhong M; Fu Y; Li C
J Med Virol; 2017 Dec; 89(12):2130-2137. PubMed ID: 28543299
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010.
Kunoee A; Nielsen J; Cowan S
Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681
[TBL] [Abstract][Full Text] [Related]
23. Perinatal and intrafamily transmission of hepatitis B virus in three generations of a low-prevalence population.
Ordög K; Szendrôi A; Szarka K; Kugler Z; Csire M; Kapusinszky B; Xie J; Csizmadia K; Brojnás J; Rusvai E; Tempfli A; Berencsi G
J Med Virol; 2003 Jun; 70(2):194-204. PubMed ID: 12696105
[TBL] [Abstract][Full Text] [Related]
24. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
[TBL] [Abstract][Full Text] [Related]
25. Continuing Decrease in Hepatitis B Virus Infection 30 Years After Initiation of Infant Vaccination Program in Taiwan.
Ni YH; Chang MH; Jan CF; Hsu HY; Chen HL; Wu JF; Chen DS
Clin Gastroenterol Hepatol; 2016 Sep; 14(9):1324-30. PubMed ID: 27155556
[TBL] [Abstract][Full Text] [Related]
26. A mass vaccination program in Taiwan against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers.
Chen DS; Hsu NH; Sung JL; Hsu TC; Hsu ST; Kuo YT; Lo KJ; Shih YT
JAMA; 1987 May; 257(19):2597-603. PubMed ID: 3573257
[TBL] [Abstract][Full Text] [Related]
27. Universal screening for hepatitis B among pregnant women led to 96% vaccination coverage among newborns of HBsAg positive mothers in Denmark.
Harder KM; Cowan S; Eriksen MB; Krarup HB; Christensen PB
Vaccine; 2011 Nov; 29(50):9303-7. PubMed ID: 22019756
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus infection in children: epidemiology, natural course and prevention in Taiwan.
Chang MH
J Formos Med Assoc; 1996 Aug; 95(8):593-8. PubMed ID: 8870428
[TBL] [Abstract][Full Text] [Related]
29. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV.
Chen HL; Lin LH; Hu FC; Lee JT; Lin WT; Yang YJ; Huang FC; Wu SF; Chen SC; Wen WH; Chu CH; Ni YH; Hsu HY; Tsai PL; Chiang CL; Shyu MK; Lee PI; Chang FY; Chang MH
Gastroenterology; 2012 Apr; 142(4):773-781.e2. PubMed ID: 22198276
[TBL] [Abstract][Full Text] [Related]
30. Minimization of hepatitis B infection by a 25-year universal vaccination program.
Ni YH; Chang MH; Wu JF; Hsu HY; Chen HL; Chen DS
J Hepatol; 2012 Oct; 57(4):730-5. PubMed ID: 22668640
[TBL] [Abstract][Full Text] [Related]
31. Trend of hepatitis B virus infection in freshmen classes at two high schools in Hualien, Taiwan from 1991 to 1999.
Lin HH; Lin SS; Chiang YM; Wang LY; Huang LC; Huang SC; Liu TT
J Med Virol; 2002 Aug; 67(4):472-6. PubMed ID: 12115991
[TBL] [Abstract][Full Text] [Related]
32. Continuing risk for hepatitis B virus transmission among Southeast Asian infants in Louisiana.
Mahoney FJ; Lawrence M; Scott C; Le Q; Lambert S; Farley TA
Pediatrics; 1995 Dec; 96(6):1113-6. PubMed ID: 7491231
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B vaccination: disease and cancer prevention-a Taiwanese experience.
Chang MH
Clin Liver Dis; 2010 Aug; 14(3):521-30. PubMed ID: 20638029
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B vaccination and prevention of hepatocellular carcinoma.
Kao JH
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):907-17. PubMed ID: 26651252
[TBL] [Abstract][Full Text] [Related]
35. [Long-term efficacy of infant hepatitis B immunization program].
Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
[TBL] [Abstract][Full Text] [Related]
36. Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan.
Hsu HY; Chang MH; Ni YH; Chen HL
Gut; 2004 Oct; 53(10):1499-503. PubMed ID: 15361503
[TBL] [Abstract][Full Text] [Related]
37. A mass hepatitis B vaccination programme in Taiwan: its preparation, results and reasons for uncompleted vaccinations.
Wong WC; Tsang KK
Vaccine; 1994; 12(3):229-34. PubMed ID: 8165855
[TBL] [Abstract][Full Text] [Related]
38. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
39. Preventing hepatitis B and hepatocellular carcinoma in South Africa: The case for a birth-dose vaccine.
Spearman CW; Sonderup MW
S Afr Med J; 2014 Jul; 104(9):610-2. PubMed ID: 25212400
[TBL] [Abstract][Full Text] [Related]
40. Prevention and control of hepatitis B virus infection in Singapore.
Goh KT
Ann Acad Med Singap; 1997 Sep; 26(5):671-81. PubMed ID: 9494677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
